Abiopharma

New Form SCHEDULE 13G/A - GRI Bio, Inc. <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001213900-26-088829 <b>Size:</b> 11 KB

New Form 424B2 - BARCLAYS BANK PLC <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001918704-26-023647 <b>Size:</b> 566 KB

Financial Statements and Related Announcement: Half Yearly Results

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001918704-26-023646 <b>Size:</b> 1 MB

New Form SCHEDULE 13G/A - ARTELO BIOSCIENCES, INC. <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001213900-26-088826 <b>Size:</b> 10 KB

New Form SCHEDULE 13G - Kandal M Venture Ltd <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001947975-26-000018 <b>Size:</b> 23 KB

enCore Energy Reports Q2 2026 Financial Results

New Form 424B2 - BANK OF AMERICA CORP /DE/ <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001918704-26-023645 <b>Size:</b> 1 MB

New Form SCHEDULE 13G/A - DoubleVerify Holdings, Inc. <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001167557-26-000184 <b>Size:</b> 8 KB

Cellectar Biosciences Reports Second Quarter 2026 Financial Results and Provides Corporate Updates

New Form FWP - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001918704-26-023643 <b>Size:</b> 1 MB

New Form SCHEDULE 13G/A - AETHLON MEDICAL INC <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001213900-26-088823 <b>Size:</b> 10 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001918704-26-023642 <b>Size:</b> 780 KB

Arcos Dorados Reports Second Quarter 2026 Financial Results

SES AI Appoints Paul Diemer to Board of Directors